ERBB2 and breast cancer: However, in other cancer types, such as NPC, HER2+ BC, esophageal cancer, pancreatic cancer, and gynecological tumors, the lesion detectability of 68Ga-MY6349 PET/CT was inferior to that of 18F-FDG PET/CT.